Citius Oncology (CTOR) Tax Rate (2023 - 2026)
Citius Oncology's (CTOR) quarterly Tax Rate came in at 1.19% in Q2 2026, up 636.0% year-over-year from 0.16% in Q2 2025, and up 37.99% quarter-over-quarter from 0.86% in Q1 2026.
Analysis
Citius Oncology (CTOR) Tax Rate (2023 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported Tax Rate for 4 consecutive years, with 1.19% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Tax Rate rose 636.0% year-over-year to 1.19% in Q2 2026; TTM through Jun 2026 was 0.41%, a 331.0% increase from a year earlier, with the FY2025 full-year figure at 4.46%, down 166.0% from the prior year.
- Tax Rate was 1.19% for Q2 2026 at Citius Oncology, up from 0.86% in the prior quarter.
- Over five years, Tax Rate peaked at 1.19% in Q2 2026 and troughed at 5.58% in Q3 2025.
- A 4-year average of 3.07% and a median of 3.34% in 2025 frame the typical range for Tax Rate.
- Across the five-year window, Tax Rate slumped 207 bps in 2025 and jumped 636 bps in 2026, its largest moves.
- Over 4 years, Tax Rate stood at 3.14% in 2023, then tumbled by 32 bps to 4.13% in 2024, then retreated by 21 bps to 5.01% in 2025, then soared by 124 bps to 1.19% in 2026.
- The last three Tax Rate figures came in at 1.19% (Q2 2026), 0.86% (Q1 2026), and 5.01% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 14.20% |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | -2.36% |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 20.98% |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 15.11% |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | -10.89% |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | -1.96% |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 7.49% |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 26.36% |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 1.34% |
| 10 | Citius Oncology | 101.41 Mn | 101.41 Mn | 1.00 Mn | 1.19% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.19% |
| Mar 31, 2026 | 0.86% |
| Dec 31, 2025 | -5.01% |
| Sep 30, 2025 | -5.58% |
| Jun 30, 2025 | -5.18% |
| Mar 31, 2025 | -3.54% |
| Dec 31, 2024 | -4.13% |
| Jun 30, 2024 | -3.11% |
| Mar 31, 2024 | -3.11% |
| Dec 31, 2023 | -3.14% |